2016
DOI: 10.1016/j.clinph.2016.06.025
|View full text |Cite
|
Sign up to set email alerts
|

Single and paired pulse transcranial magnetic stimulation in drug naïve epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
38
1
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 29 publications
(42 citation statements)
references
References 170 publications
1
38
1
2
Order By: Relevance
“…For example, Appendix B shows a maximal increase or decrease in LICI of around 65% due to a change in coil positioning. However, differences between patients with epilepsy and healthy controls at ISI 250 ms have been reported to be three times as large: inhibition in controls (mean ± SD: 68.3 ± 37.0%), but facilitation in patients (generalized epilepsy: 273.0 ± 106.2%, and ipsilateral hemisphere focal epilepsy: 244.0 ± 76.4%) (Badawy et al 2007 , 2014 , 2017 ; de Goede et al 2016 ). Furthermore, in successfully treated patients facilitation may normalize to inhibition over time, while LICI remains increased in refractory patients (Badawy et al 2013 ).…”
Section: Discussionmentioning
confidence: 99%
“…For example, Appendix B shows a maximal increase or decrease in LICI of around 65% due to a change in coil positioning. However, differences between patients with epilepsy and healthy controls at ISI 250 ms have been reported to be three times as large: inhibition in controls (mean ± SD: 68.3 ± 37.0%), but facilitation in patients (generalized epilepsy: 273.0 ± 106.2%, and ipsilateral hemisphere focal epilepsy: 244.0 ± 76.4%) (Badawy et al 2007 , 2014 , 2017 ; de Goede et al 2016 ). Furthermore, in successfully treated patients facilitation may normalize to inhibition over time, while LICI remains increased in refractory patients (Badawy et al 2013 ).…”
Section: Discussionmentioning
confidence: 99%
“…Which repeatability for each ISI is required ultimately depends on the research question and study population. For example, in epilepsy research it appears that especially ISIs 2, 5, 250 and 300 ms differ significantly between patients and controls (de Goede et al, 2016). Therefore repeatability should be optimal for these particular ISIs, but not necessarily for the others.…”
Section: Discussionmentioning
confidence: 99%
“…9 A number of studies have attempted to identify TMS-based biomarkers for diagnosis or prediction of treatment response in the epilepsies. 10,11 In general, these studies have involved relatively heterogenous patient groups, which may have contributed to the paucity of clinically adopted markers. 10,11 Studying TMS in genetically-defined patient groups may decrease inter-individual variability and increase power for detecting clinically useful signatures of pathophysiological processes yielding biomarkers for diagnosis and treatment of these conditions.…”
Section: Introductionmentioning
confidence: 99%
“…10,11 In general, these studies have involved relatively heterogenous patient groups, which may have contributed to the paucity of clinically adopted markers. 10,11 Studying TMS in genetically-defined patient groups may decrease inter-individual variability and increase power for detecting clinically useful signatures of pathophysiological processes yielding biomarkers for diagnosis and treatment of these conditions. This approach has already been employed for several genetic conditions of relevance to epilepsy, which we now review.…”
Section: Introductionmentioning
confidence: 99%